Auris Health Lux Capital Brings Together Health and Technology Investments

Auris Health Lux Capital is a pioneering investment firm that's changing the game by bringing together health and technology investments. They're not just about throwing money at ideas, but about creating a platform that fosters innovation and collaboration between entrepreneurs, scientists, and industry experts.

Their unique approach has already yielded impressive results, with a portfolio that includes cutting-edge medical devices and digital health solutions. These investments have the potential to transform the way we approach healthcare and make a real difference in people's lives.

By merging the worlds of health and technology, Auris Health Lux Capital is creating a new paradigm for investment and innovation. This convergence of expertise and resources is unlocking new possibilities for medical breakthroughs and improving patient outcomes.

Intriguing read: Lux Capital Corp

Auris Health has raised a significant amount of funding to support its Monarch robotic interventional platform, with a total of $700 million raised for the platform.

The company closed a $220 million equity financing round, led by Partner Fund Management, to help support its commercialization efforts.

Auris Health's robotic Monarch platform has FDA clearance for diagnostic and therapeutic bronchoscopic procedures, featuring a controller interface for navigating the integrated flexible robotic endoscope.

The platform combines traditional endoscopic views with computer-assisted navigation based on 3D patient models, allowing for high accuracy in reaching lung nodules and biopsy tissue.

In the past, Auris Surgical Robotics raised a massive $280 million in a Series D round of financing, led by Coatue Management, with money coming from 39 investors.

The company is looking to raise an additional $4.9 million before closing the round, with the 1st sale recorded on April 5.

The funding will enable Auris Health to expand its commercialization efforts for endobronchial applications and support its mission to pioneer the next era of medical intervention.

Auris Health closed a $220 million equity financing round to support its next-generation Monarch robotic interventional platform.

This funding brings the total raised for the Monarch surgical platform up to $700 million, a significant milestone for the company.

The round was led by Partner Fund Management and joined by newly invested Wellington Management, D1 Capital Partners, and Senator Investment Group, along with existing investors Mithril Capital, Lux Capital, and Viking Global Investors.

Auris Health's robotic Monarch platform has FDA clearance for diagnostic and therapeutic bronchoscopic procedures.

The system features a controller interface for navigating the integrated flexible robotic endoscope into the periphery of the lung and combines traditional endoscopic views with computer-assisted navigation based on 3D patient models.

Auris Health's founder and CEO, Dr. Frederic Moll, expressed his gratitude for the support of the investors, stating that it will be instrumental in transitioning the company into a commercial-stage company.

The company plans to expand its commercialization efforts for endobronchial applications and support its mission to pioneer the next era of medical intervention across a broader spectrum of procedures.

Auris Health previously raised $280 million in a Series D round of financing, led by Coatue Management and joined by Mithril, Lux Capital, and Highland Capital Partners.

The company is looking to raise an additional $4.9 million before closing the round, with the first sale recorded on April 5.

Auris Health's platform integrates the latest advancements in robotics, micro-instrumentation, sensing, and data science to achieve breakthroughs and deliver improved clinical outcomes for patients.

Dr. Frederic Moll has been a pioneer in medical robotics, co-founding companies like Intuitive Surgical and Restoration Robotics.

Intriguing read: Working Capital Management Examples

Auris Health has received significant investments from Lux Capital, a venture capital firm that focuses on emerging technologies.

Lux Capital's investment in Auris Health has helped the company develop its robotic-assisted surgery technology.

Auris Health's robotic-assisted surgery system is designed to enhance surgical precision and reduce recovery time for patients.

The company's technology has the potential to revolutionize the field of surgery and improve patient outcomes.

Auris Health's robotic-assisted surgery system is currently being used in various medical procedures, including lung cancer surgery.

Intriguing read: Josh Wolfe Lux Capital